- posted in News Release
Toronto, ON, Canada, February 28, 2012 – Bio Pharma Services Inc. (BPSI) announced that Dr. Fethi Trabelsi has joined the company in the role of Vice-President of Scientific Affairs starting Feb 27th, 2012. Dr. Trabelsi brings to BioPharma extensive experience and knowledge in the Bioequivalence and Phase I fields. He is well known and highly regarded in the industry and has been in various management roles in the last 15 years. Previous to BioPharma, Dr. Trabelsi had senior management posts at Pharmanet, Anapharm and MDS Pharma in Quebec, Canada.
As Vice-President of Scientific Affairs for BioPharma, Dr. Trabelsi will also serve as a member of its Executive Committee, reporting directly to the CEO, Mr. Renzo DiCarlo. Dr. Trabelsi will be responsible for the BioPharmaceutics department, which includes Medical Writing, Pharmacokinetics, Statistics, and Data Management, and BioPharma’s new Bioanalytical Laboratory, in Toronto, Canada.
Mr. DiCarlo said, “We are thrilled to have Dr. Fethi Trabelsi join the BioPharma Services team as our new Vice-President of Scientific Affairs responsible for our scientific and bioanalytical mandate and teams. Dr. Trabelsi is extremely familiar with the early stage business having working with a number of large contract research firms, such as Anapharm. His contributions to the industry have been felt by many pharmaceutical sponsors through his invaluable regulatory and scientific contributions to European, Asian and North American drug submissions and product approvals.”
About BioPharma Services Inc.
BioPharma Services Inc. is a physician-owned, physician-run, FDA-inspected, UK MHRA-inspected, and Health Canada-inspected Canadian Contract Research Organization (CRO) which specializes in the conduct of Bioequivalence (BE) Studies for generic pharmaceutical companies, and Phase I/IIa clinical trials for innovative pharmaceutical companies from US, Canada, Australia and Europe. The company currently has a modern 158-bed clinical facility based in Toronto, Canada. It is privately held, and it is headquartered in Toronto, Canada.
For more information regarding this release, please contact Ms. Lorelei Lutter at llutter[at]biopharmaservices.ca